• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and Japan Non-invasive Cancer Diagnosis Market Size, Status and Forecast 2020-2026

report cover
  • 29 October 2020
  • Pharmaceuticals
  • 96 Pages
  • Report Code: 24LS-21691
  • Formate :   
Download FREE Report Sample Download PDF File

Non invasive Cancer Diagnosis -MARKET ADVISORY SERVICES

Global Non-invasive Cancer Diagnosis Scope and Market Size
Non-invasive Cancer Diagnosis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-invasive Cancer Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Others

Market segment by Application, split into
Blood Cancer
Solid Tumors
Breast Cancer
Lung Cancer
Others

Based on regional and country-level analysis, the Non-invasive Cancer Diagnosis market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Non-invasive Cancer Diagnosis market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Gen-Probe Inc.
A&G Pharmaceutical
Affymetrix Inc.
Digene Corporation
Quest Diagnostics Inc.
BioView Inc.
LabCorp
AVIVA Biosciences Corporation
Precision Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Clinical Chemistry
1.2.3 Immunochemistry/Immunoassay
1.2.4 Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Non-invasive Cancer Diagnosis Market Share by Application: 2020 VS 2026
1.3.2 Blood Cancer
1.3.3 Solid Tumors
1.3.4 Breast Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Non-invasive Cancer Diagnosis Market Perspective (2015-2026)
2.2 Global Non-invasive Cancer Diagnosis Growth Trends by Regions
2.2.1 Non-invasive Cancer Diagnosis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non-invasive Cancer Diagnosis Historic Market Share by Regions (2015-2020)
2.2.3 Non-invasive Cancer Diagnosis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Non-invasive Cancer Diagnosis Players by Market Size
3.1.1 Global Top Non-invasive Cancer Diagnosis Players by Revenue (2015-2020)
3.1.2 Global Non-invasive Cancer Diagnosis Revenue Market Share by Players (2015-2020)
3.2 Global Non-invasive Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-invasive Cancer Diagnosis Revenue
3.4 Global Non-invasive Cancer Diagnosis Market Concentration Ratio
3.4.1 Global Non-invasive Cancer Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Cancer Diagnosis Revenue in 2019
3.5 Key Players Non-invasive Cancer Diagnosis Area Served
3.6 Key Players Non-invasive Cancer Diagnosis Product Solution and Service
3.7 Date of Enter into Non-invasive Cancer Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Non-invasive Cancer Diagnosis Breakdown Data by Type (2015-2026)
4.1 Global Non-invasive Cancer Diagnosis Historic Market Size by Type (2015-2020)
4.2 Global Non-invasive Cancer Diagnosis Forecasted Market Size by Type (2021-2026)

5 Non-invasive Cancer Diagnosis Breakdown Data by Application (2015-2026)
5.1 Global Non-invasive Cancer Diagnosis Historic Market Size by Application (2015-2020)
5.2 Global Non-invasive Cancer Diagnosis Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Non-invasive Cancer Diagnosis Market Size (2015-2026)
6.2 North America Non-invasive Cancer Diagnosis Market Size by Type (2015-2020)
6.3 North America Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)
6.4 North America Non-invasive Cancer Diagnosis Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Non-invasive Cancer Diagnosis Market Size (2015-2026)
7.2 Europe Non-invasive Cancer Diagnosis Market Size by Type (2015-2020)
7.3 Europe Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)
7.4 Europe Non-invasive Cancer Diagnosis Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Non-invasive Cancer Diagnosis Market Size (2015-2026)
8.2 China Non-invasive Cancer Diagnosis Market Size by Type (2015-2020)
8.3 China Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)
8.4 China Non-invasive Cancer Diagnosis Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Non-invasive Cancer Diagnosis Market Size (2015-2026)
9.2 Japan Non-invasive Cancer Diagnosis Market Size by Type (2015-2020)
9.3 Japan Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)
9.4 Japan Non-invasive Cancer Diagnosis Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Non-invasive Cancer Diagnosis Market Size (2015-2026)
10.2 Southeast Asia Non-invasive Cancer Diagnosis Market Size by Type (2015-2020)
10.3 Southeast Asia Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)
10.4 Southeast Asia Non-invasive Cancer Diagnosis Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 Gen-Probe Inc.
11.1.1 Gen-Probe Inc. Company Details
11.1.2 Gen-Probe Inc. Business Overview
11.1.3 Gen-Probe Inc. Non-invasive Cancer Diagnosis Introduction
11.1.4 Gen-Probe Inc. Revenue in Non-invasive Cancer Diagnosis Business (2015-2020))
11.1.5 Gen-Probe Inc. Recent Development
11.2 A&G Pharmaceutical
11.2.1 A&G Pharmaceutical Company Details
11.2.2 A&G Pharmaceutical Business Overview
11.2.3 A&G Pharmaceutical Non-invasive Cancer Diagnosis Introduction
11.2.4 A&G Pharmaceutical Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
11.2.5 A&G Pharmaceutical Recent Development
11.3 Affymetrix Inc.
11.3.1 Affymetrix Inc. Company Details
11.3.2 Affymetrix Inc. Business Overview
11.3.3 Affymetrix Inc. Non-invasive Cancer Diagnosis Introduction
11.3.4 Affymetrix Inc. Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
11.3.5 Affymetrix Inc. Recent Development
11.4 Digene Corporation
11.4.1 Digene Corporation Company Details
11.4.2 Digene Corporation Business Overview
11.4.3 Digene Corporation Non-invasive Cancer Diagnosis Introduction
11.4.4 Digene Corporation Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
11.4.5 Digene Corporation Recent Development
11.5 Quest Diagnostics Inc.
11.5.1 Quest Diagnostics Inc. Company Details
11.5.2 Quest Diagnostics Inc. Business Overview
11.5.3 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Introduction
11.5.4 Quest Diagnostics Inc. Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
11.5.5 Quest Diagnostics Inc. Recent Development
11.6 BioView Inc.
11.6.1 BioView Inc. Company Details
11.6.2 BioView Inc. Business Overview
11.6.3 BioView Inc. Non-invasive Cancer Diagnosis Introduction
11.6.4 BioView Inc. Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
11.6.5 BioView Inc. Recent Development
11.7 LabCorp
11.7.1 LabCorp Company Details
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Non-invasive Cancer Diagnosis Introduction
11.7.4 LabCorp Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
11.7.5 LabCorp Recent Development
11.8 AVIVA Biosciences Corporation
11.8.1 AVIVA Biosciences Corporation Company Details
11.8.2 AVIVA Biosciences Corporation Business Overview
11.8.3 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Introduction
11.8.4 AVIVA Biosciences Corporation Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
11.8.5 AVIVA Biosciences Corporation Recent Development
11.9 Precision Therapeutics
11.9.1 Precision Therapeutics Company Details
11.9.2 Precision Therapeutics Business Overview
11.9.3 Precision Therapeutics Non-invasive Cancer Diagnosis Introduction
11.9.4 Precision Therapeutics Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
11.9.5 Precision Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables

Table 1. Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 3. Key Players of Clinical Chemistry

Table 4. Key Players of Immunochemistry/Immunoassay

Table 5. Key Players of Molecular Diagnostics

Table 6. Key Players of Others

Table 7. Global Non-invasive Cancer Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 8. Global Non-invasive Cancer Diagnosis Market Size by Regions (US$ Million): 2020 VS 2026

Table 9. Global Non-invasive Cancer Diagnosis Market Size by Regions (2015-2020) (US$ Million)

Table 10. Global Non-invasive Cancer Diagnosis Market Share by Regions (2015-2020)

Table 11. Global Non-invasive Cancer Diagnosis Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 12. Global Non-invasive Cancer Diagnosis Market Share by Regions (2021-2026)

Table 13. Non-invasive Cancer Diagnosis Market Market Trends

Table 14. Non-invasive Cancer Diagnosis Market Drivers

Table 15. Non-invasive Cancer Diagnosis Market Challenges

Table 16. Non-invasive Cancer Diagnosis Market Restraints

Table 17. Global Non-invasive Cancer Diagnosis Revenue by Players (2015-2020) (US$ Million)

Table 18. Global Non-invasive Cancer Diagnosis Market Share by Players (2015-2020)

Table 19. Global Top Non-invasive Cancer Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-invasive Cancer Diagnosis as of 2019)

Table 20. Global Non-invasive Cancer Diagnosis by Players Market Concentration Ratio (CR5 and HHI)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Non-invasive Cancer Diagnosis Product Solution and Service

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Non-invasive Cancer Diagnosis Market Size by Type (2015-2020) (US$ Million)

Table 25. Global Non-invasive Cancer Diagnosis Market Size Share by Type (2015-2020)

Table 26. Global Non-invasive Cancer Diagnosis Revenue Market Share by Type (2021-2026)

Table 27. Global Non-invasive Cancer Diagnosis Market Size Share by Application (2015-2020)

Table 28. Global Non-invasive Cancer Diagnosis Market Size by Application (2015-2020) (US$ Million)

Table 29. Global Non-invasive Cancer Diagnosis Market Size Share by Application (2021-2026)

Table 30. North America Non-invasive Cancer Diagnosis Market Size by Type (2015-2020) (US$ Million)

Table 31. North America Non-invasive Cancer Diagnosis Market Share by Type (2015-2020)

Table 32. North America Non-invasive Cancer Diagnosis Market Size by Application (2015-2020) (US$ Million)

Table 33. North America Non-invasive Cancer Diagnosis Market Share by Application (2015-2020)

Table 34. North America Non-invasive Cancer Diagnosis Market Size by Country (US$ Million) (2015-2020)

Table 35. North America Non-invasive Cancer Diagnosis Market Share by Country (2015-2020)

Table 36. Europe Non-invasive Cancer Diagnosis Market Size by Type (2015-2020) (US$ Million)

Table 37. Europe Non-invasive Cancer Diagnosis Market Share by Type (2015-2020)

Table 38. Europe Non-invasive Cancer Diagnosis Market Size by Application (2015-2020) (US$ Million)

Table 39. Europe Non-invasive Cancer Diagnosis Market Share by Application (2015-2020)

Table 40. Europe Non-invasive Cancer Diagnosis Market Size by Country (US$ Million) (2015-2020)

Table 41. Europe Non-invasive Cancer Diagnosis Market Share by Country (2015-2020)

Table 42. China Non-invasive Cancer Diagnosis Market Size by Type (2015-2020) (US$ Million)

Table 43. China Non-invasive Cancer Diagnosis Market Share by Type (2015-2020)

Table 44. China Non-invasive Cancer Diagnosis Market Size by Application (2015-2020) (US$ Million)

Table 45. China Non-invasive Cancer Diagnosis Market Share by Application (2015-2020)

Table 46. China Non-invasive Cancer Diagnosis Market Size by Region (US$ Million) (2015-2020)

Table 47. China Non-invasive Cancer Diagnosis Market Share by Region (2015-2020)

Table 48. Japan Non-invasive Cancer Diagnosis Market Size by Type (2015-2020) (US$ Million)

Table 49. Japan Non-invasive Cancer Diagnosis Market Share by Type (2015-2020)

Table 50. Japan Non-invasive Cancer Diagnosis Market Size by Application (2015-2020) (US$ Million)

Table 51. Japan Non-invasive Cancer Diagnosis Market Share by Application (2015-2020)

Table 52. Japan Non-invasive Cancer Diagnosis Market Size by Country (US$ Million) (2015-2020)

Table 53. Japan Non-invasive Cancer Diagnosis Market Share by Country (2015-2020)

Table 54. Southeast Asia Non-invasive Cancer Diagnosis Market Size by Type (2015-2020) (US$ Million)

Table 55. Southeast Asia Non-invasive Cancer Diagnosis Market Share by Type (2015-2020)

Table 56. Southeast Asia Non-invasive Cancer Diagnosis Market Size by Application (2015-2020) (US$ Million)

Table 57. Southeast Asia Non-invasive Cancer Diagnosis Market Share by Application (2015-2020)

Table 58. Southeast Asia Non-invasive Cancer Diagnosis Market Size by Country (US$ Million) (2015-2020)

Table 59. Southeast Asia Non-invasive Cancer Diagnosis Market Share by Country (2015-2020)

Table 60. Gen-Probe Inc. Company Details

Table 61. Gen-Probe Inc. Business Overview

Table 62. Gen-Probe Inc. Product

Table 63. Gen-Probe Inc. Revenue in Non-invasive Cancer Diagnosis Business (2015-2020) (US$ Million)

Table 64. Gen-Probe Inc. Recent Development

Table 65. A&G Pharmaceutical Company Details

Table 66. A&G Pharmaceutical Business Overview

Table 67. A&G Pharmaceutical Product

Table 68. A&G Pharmaceutical Revenue in Non-invasive Cancer Diagnosis Business (2015-2020) (US$ Million)

Table 69. A&G Pharmaceutical Recent Development

Table 70. Affymetrix Inc. Company Details

Table 71. Affymetrix Inc. Business Overview

Table 72. Affymetrix Inc. Product

Table 73. Affymetrix Inc. Revenue in Non-invasive Cancer Diagnosis Business (2015-2020) (US$ Million)

Table 74. Affymetrix Inc. Recent Development

Table 75. Digene Corporation Company Details

Table 76. Digene Corporation Business Overview

Table 77. Digene Corporation Product

Table 78. Digene Corporation Revenue in Non-invasive Cancer Diagnosis Business (2015-2020) (US$ Million)

Table 79. Digene Corporation Recent Development

Table 80. Quest Diagnostics Inc. Company Details

Table 81. Quest Diagnostics Inc. Business Overview

Table 82. Quest Diagnostics Inc. Product

Table 83. Quest Diagnostics Inc. Revenue in Non-invasive Cancer Diagnosis Business (2015-2020) (US$ Million)

Table 84. Quest Diagnostics Inc. Recent Development

Table 85. BioView Inc. Company Details

Table 86. BioView Inc. Business Overview

Table 87. BioView Inc. Product

Table 88. BioView Inc. Revenue in Non-invasive Cancer Diagnosis Business (2015-2020) (US$ Million)

Table 89. BioView Inc. Recent Development

Table 90. LabCorp Company Details

Table 91. LabCorp Business Overview

Table 92. LabCorp Product

Table 93. LabCorp Revenue in Non-invasive Cancer Diagnosis Business (2015-2020) (US$ Million)

Table 94. LabCorp Recent Development

Table 95. AVIVA Biosciences Corporation Business Overview

Table 96. AVIVA Biosciences Corporation Product

Table 97. AVIVA Biosciences Corporation Company Details

Table 98. AVIVA Biosciences Corporation Revenue in Non-invasive Cancer Diagnosis Business (2015-2020) (US$ Million)

Table 99. AVIVA Biosciences Corporation Recent Development

Table 100. Precision Therapeutics Company Details

Table 101. Precision Therapeutics Business Overview

Table 102. Precision Therapeutics Product

Table 103. Precision Therapeutics Revenue in Non-invasive Cancer Diagnosis Business (2015-2020) (US$ Million)

Table 104. Precision Therapeutics Recent Development

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-invasive Cancer Diagnosis Market Share by Type: 2020 VS 2026

Figure 2. Clinical Chemistry Features

Figure 3. Immunochemistry/Immunoassay Features

Figure 4. Molecular Diagnostics Features

Figure 5. Others Features

Figure 6. Global Non-invasive Cancer Diagnosis Market Share by Application: 2020 VS 2026

Figure 7. Blood Cancer Case Studies

Figure 8. Solid Tumors Case Studies

Figure 9. Breast Cancer Case Studies

Figure 10. Lung Cancer Case Studies

Figure 11. Others Case Studies

Figure 12. Non-invasive Cancer Diagnosis Report Years Considered

Figure 13. Global Non-invasive Cancer Diagnosis Market Size (US$ Million), YoY Growth 2015-2026

Figure 14. Global Non-invasive Cancer Diagnosis Market Share by Regions: 2020 VS 2026

Figure 15. Global Non-invasive Cancer Diagnosis Market Share by Regions (2021-2026)

Figure 16. Global Non-invasive Cancer Diagnosis Market Share by Players in 2019

Figure 17. Global Top Non-invasive Cancer Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-invasive Cancer Diagnosis as of 2019

Figure 18. The Top 10 and 5 Players Market Share by Non-invasive Cancer Diagnosis Revenue in 2019

Figure 19. North America Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 20. United States Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 21. Canada Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 22. Europe Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 23. Germany Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 24. France Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 25. U.K. Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 26. Italy Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 27. Russia Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 28. Nordic Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 29. Rest of Europe Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 30. Asia-Pacific Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 31. China Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 32. Japan Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 33. South Korea Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 34. Southeast Asia Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 35. India Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 36. Australia Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 37. Rest of Asia-Pacific Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 38. Latin America Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 39. Mexico Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 40. Brazil Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 41. Middle East & Africa Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 42. Turkey Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 43. Saudi Arabia Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 44. UAE Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 45. Rest of Middle East & Africa Non-invasive Cancer Diagnosis Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 46. Gen-Probe Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2015-2020)

Figure 47. A&G Pharmaceutical Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2015-2020)

Figure 48. Affymetrix Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2015-2020)

Figure 49. Digene Corporation Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2015-2020)

Figure 50. Quest Diagnostics Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2015-2020)

Figure 51. BioView Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2015-2020)

Figure 52. LabCorp Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2015-2020)

Figure 53. AVIVA Biosciences Corporation Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2015-2020)

Figure 54. Precision Therapeutics Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2015-2020)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

Gen-Probe Inc.

A&G Pharmaceutical

Affymetrix Inc.

Digene Corporation

Quest Diagnostics Inc.

BioView Inc.

LabCorp

AVIVA Biosciences Corporation

Precision Therapeutics

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2925

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase